Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Clinical administration of cinacalcet in parathyroid diseases
View through CrossRef
Cinacalcet has emerged as an effective therapeutic option for the management of secondary hyperparathyroidism (SHPT) and chronic kidney disease-mineral and bone disorder (CKD-MBD). Through its modulation of the calcium-sensing receptor (CaSR), cinacalcet demonstrates considerable clinical benefits in maintaining parathyroid hormone and serum calcium levels within target ranges. It offers a valuable addition to the available treatment options for patients with these conditions. Cinacalcet binds to the CaSR on parathyroid cells, increasing its sensitivity to extracellular calcium. This results in decreased parathyroid hormone (PTH; parathormone), release through inhibition of intracellular signaling pathways involved in PTH synthesis and secretion. Cinacalcet also indirectly reduces serum calcium and phosphorus levels by suppressing PTH-mediated bone resorption and enhancing renal phosphate excretion.
Maad Rayan Publishing Company
Title: Clinical administration of cinacalcet in parathyroid diseases
Description:
Cinacalcet has emerged as an effective therapeutic option for the management of secondary hyperparathyroidism (SHPT) and chronic kidney disease-mineral and bone disorder (CKD-MBD).
Through its modulation of the calcium-sensing receptor (CaSR), cinacalcet demonstrates considerable clinical benefits in maintaining parathyroid hormone and serum calcium levels within target ranges.
It offers a valuable addition to the available treatment options for patients with these conditions.
Cinacalcet binds to the CaSR on parathyroid cells, increasing its sensitivity to extracellular calcium.
This results in decreased parathyroid hormone (PTH; parathormone), release through inhibition of intracellular signaling pathways involved in PTH synthesis and secretion.
Cinacalcet also indirectly reduces serum calcium and phosphorus levels by suppressing PTH-mediated bone resorption and enhancing renal phosphate excretion.
Related Results
Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Primary and Metastatic Parathyroid Malignancies: A Rare or Underdiagnosed Condition?
Objective:
Parathyroid gland malignancies are considered rare. The most common of these tumor types is primary parathyroid carcinoma. Metastatic spread from other...
P1398EFFECTS OF CONVERTING FROM CINACALCET TO ETELCALCETIDE
P1398EFFECTS OF CONVERTING FROM CINACALCET TO ETELCALCETIDE
Abstract
Background and Aims
Secondary hyperparathyroidism is a common problem in patients undergoing chronic hemodialysis and i...
Cross-Expression of Thymic and Parathyroid Hormone Receptors Supports the Hypothesis of a Parathyroid–Thymus Port System
Cross-Expression of Thymic and Parathyroid Hormone Receptors Supports the Hypothesis of a Parathyroid–Thymus Port System
The thymus and parathyroid glands share a common embryological origin from the third pharyngeal pouch, yet their potential morphological and functional interconnections remain insu...
De novo
expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism
De novo
expression of transforming growth factor-α in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism
Abstract
Background.
The factors involved in abnormal parathyroid cell secretory function and growth in patients with pri...
Parathyroid gland identification and angiography classification using simple machine learning methods
Parathyroid gland identification and angiography classification using simple machine learning methods
Abstract
Background
Near-infrared indocyanine green angiography allows experienced surgeons to reliably evaluate parathyroid gla...
Long-Term Clinical Practice Experience with Cinacalcet for Treatment of Hypercalcemic Hyperparathyroidism after Kidney Transplantation
Long-Term Clinical Practice Experience with Cinacalcet for Treatment of Hypercalcemic Hyperparathyroidism after Kidney Transplantation
Within this prospective, open-label, self-controlled study, we evaluated the long-term effects of the calcimimetic cinacalcet on calcium and phosphate homeostasis in 44 kidney tran...
Data mining study on adverse events of cinacalcet based on JADER database
Data mining study on adverse events of cinacalcet based on JADER database
Abstract
Background
Cinacalcet is the first calcium-sensing receptor agonist (calcimimetic) primarily indicated for the management of secondary hyperparathyroidism in pati...
Pseudohypoparathyroidism versus signaling disorder: A case report
Pseudohypoparathyroidism versus signaling disorder: A case report
Pseudohypoparathyroidism is a terminology used to describe a group of metabolic disorders characterized by parathyroid hormone resistance. Patients with pseudohypoparathyroidism ha...